Posted by choysun > 1 hour ago | Report Abuse Lecanemab! Hahaha ----------
Madhav Thambisetty forgot to add the fact that lecanemab increases NfL + accelerated brain shrinkage. These are very strong indications that the patients' brains are actually degenerating at a faster rate!
The ratings house noted: “We estimate aggregate revenue for Las Vegas’s strip operators will only recover to 90 percent of 2019, by end-2023, and expect Resorts World Las Vegas to reach fully ramped-up EBITDA of US$350 million by end-2024.”
Resorts World Las Vegas (RWLV) has announced its financial results for the three months ended September 30. The company registered $230m revenue, up by 11.7 per cent quarter-to-quarter. EBITDA was $52m, up 52.9 per cent.
Resorts World Las Vegas achieved EBITDA of USD195 million in 2023, if revenue grows by 20% in 2024, then it may well achieve EBITDA of USD350 million in 2024.
But it is still not quite enough to turn in a profit as depreciation charge of USD200m and interest expense of USD230m will drag it into a small pretax loss in 2024.
I estimate that it may turn in a profit in 2025 if revenue continues to grow at 10-20% in 2025.
Expect almost at bottom if <4.70. Prepare your bullets to add for May 1stQ results release. Genting short term share price movement is very difficult to predict, only long term can. Continue to monitor US small bank debt and exposure to commercial property issues
Druckenmiller almost always thinks long term and that’s the open secret behind his success. Earlier this year, in an interview with How Leaders Lead with David Novak, Druckenmiller advised investors never to invest in the present and instead keep the next 18-24 months in mind and try to imagine how the world would be in the future.
Druckenmiller Avoids "Lazy Longs"
Druckenmiller isn’t a huge fan of portfolio diversification. He said during the interview that if you really believe in a company, you’d take “massive” positions in it instead of putting your money in hundreds of companies. He said legendary investors like Warren Buffett, Carl Icahn and George Soros invest in a handful of companies they really like and believe in. Druckenmiller said instead of having “lazy longs” in your portfolio, if you put your money in just a few companies, you won’t get careless in the investing game.
Donald Trump has today made $5 billion in just minutes after his company Trump Media and Technology went public this morning and the share price leapt 50%. Why not Genting?
@AngTayKor, may I know what is the message you are hinting at? Are you suggesting that TauRx has ...good news coming soon? Also, could you share your confidence level regarding TauRx's chances of getting FDA approval?
Druckenmiller almost always thinks long term and that’s the open secret behind his success. Earlier this year, in an interview with How Leaders Lead with David Novak, Druckenmiller advised investors never to invest in the present and instead keep the next 18-24 months in mind and try to imagine how the world would be in the future.
Druckenmiller Avoids "Lazy Longs"
Druckenmiller isn’t a huge fan of portfolio diversification. He said during the interview that if you really believe in a company, you’d take “massive” positions in it instead of putting your money in hundreds of companies. He said legendary investors like Warren Buffett, Carl Icahn and George Soros invest in a handful of companies they really like and believe in. Druckenmiller said instead of having “lazy longs” in your portfolio, if you put your money in just a few companies, you won’t get careless in the investing game.
@Michael, Im just sharing an article abt hedge fund legend Stanley Druckenmiller, no special meaning. Please refer to my old post over 2 months ago on MHRA and the corrupted FDA.
--------------------- Posted by AngTayKor > 2 months ago | Report Abuse
Posted by Kikilala3188 > | Report Abuse Taurx when will it be announcing? Especially U.K. FDA approval --------
ATK: UK MHRA's final decision on CA is unlikely to be within 2024. We still have to file in more submissions which will take abt 5 to 6 months to complete it, followed by another 6 to 9 months for the regulator's final decision.
FDA delayed our Type C meeting request (supposed to be end Jan, before Taurx AGM on 6 Feb @6pm). We are not even sure if FDA will agree to consider HMTM using the Accelerated Approval pathway. If yes, I think FDA's final decision for AA will probably be at least 1.5yrs away.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
choysun
4,227 posts
Posted by choysun > 2 days ago | Report Abuse
Lecanemab! Hahaha